PAVmed PE Ratio 2015-2025 | PAVM
Current and historical p/e ratio for PAVmed (PAVM) from 2015 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. PAVmed PE ratio as of August 29, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| PAVmed PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-29 | 0.49 | 0.26 | |
| 2025-06-30 | 0.60 | $1.90 | 0.32 |
| 2025-03-31 | 0.72 | $0.71 | 1.02 |
| 2024-12-31 | 0.63 | $-2.25 | 0.00 |
| 2024-09-30 | 1.23 | $-4.35 | 0.00 |
| 2024-06-30 | 0.82 | $-8.19 | 0.00 |
| 2024-03-31 | 2.14 | $-9.10 | 0.00 |
| 2023-12-31 | 4.12 | $-9.33 | 0.00 |
| 2023-09-30 | 4.42 | $-10.79 | 0.00 |
| 2023-06-30 | 6.12 | $-12.74 | 0.00 |
| 2023-03-31 | 5.60 | $-14.99 | 0.00 |
| 2022-12-31 | 7.20 | $-15.14 | 0.00 |
| 2022-09-30 | 12.90 | $-14.69 | 0.00 |
| 2022-06-30 | 14.02 | $-12.59 | 0.00 |
| 2022-03-31 | 19.80 | $-10.34 | 0.00 |
| 2021-12-31 | 36.90 | $-9.30 | 0.00 |
| 2021-09-30 | 128.10 | $-8.85 | 0.00 |
| 2021-06-30 | 96.00 | $-8.25 | 0.00 |
| 2021-03-31 | 66.60 | $-8.10 | 0.00 |
| 2020-12-31 | 31.80 | $-11.09 | 0.00 |
| 2020-09-30 | 26.70 | $-11.39 | 0.00 |
| 2020-06-30 | 31.65 | $-11.24 | 0.00 |
| 2020-03-31 | 29.70 | $-11.24 | 0.00 |
| 2019-12-31 | 18.00 | $-8.25 | 0.00 |
| 2019-09-30 | 14.38 | $-9.30 | 0.00 |
| 2019-06-30 | 17.10 | $-9.60 | 0.00 |
| 2019-03-31 | 16.50 | $-11.69 | 0.00 |
| 2018-12-31 | 14.43 | $-12.89 | 0.00 |
| 2018-09-30 | 19.50 | $-9.30 | 0.00 |
| 2018-06-30 | 14.25 | $-13.49 | 0.00 |
| 2018-03-31 | 24.60 | $-10.64 | 0.00 |
| 2017-12-31 | 34.28 | $-12.29 | 0.00 |
| 2017-09-30 | 81.45 | $-13.94 | 0.00 |
| 2017-06-30 | 67.57 | $-10.05 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.010B | $0.003B |
| PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.932B | 22.37 |
| Intuitive Surgical (ISRG) | United States | $169.861B | 70.41 |
| IDEXX Laboratories (IDXX) | United States | $51.765B | 53.87 |
| Edwards Lifesciences (EW) | United States | $47.690B | 31.61 |
| Alcon (ALC) | Switzerland | $39.183B | 26.31 |
| IQVIA Holdings (IQV) | United States | $32.084B | 18.13 |
| DexCom (DXCM) | United States | $29.443B | 44.17 |
| Mettler-Toledo (MTD) | United States | $26.431B | 31.37 |
| STERIS (STE) | Ireland | $24.108B | 25.66 |
| Waters (WAT) | United States | $17.717B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.161B | 0.00 |
| Hologic (HOLX) | United States | $14.818B | 16.05 |
| Penumbra (PEN) | United States | $10.595B | 77.40 |
| Globus Medical (GMED) | United States | $8.256B | 19.04 |
| Sysmex ADR (SSMXY) | Japan | $8.070B | 25.64 |
| Masimo (MASI) | United States | $7.657B | 25.77 |
| Teleflex (TFX) | United States | $5.578B | 9.00 |
| Glaukos (GKOS) | United States | $5.538B | 0.00 |
| TransMedics (TMDX) | United States | $3.979B | 60.48 |
| Integer Holdings (ITGR) | United States | $3.762B | 18.77 |
| LivaNova (LIVN) | United Kingdom | $3.028B | 17.33 |
| Alphatec Holdings (ATEC) | United States | $2.372B | 0.00 |
| Veracyte (VCYT) | United States | $2.356B | 32.55 |
| PROCEPT BioRobotics (PRCT) | United States | $2.244B | 0.00 |
| Artivion (AORT) | United States | $2.067B | 104.31 |
| Nihon Kohden (NHNKY) | Japan | $1.940B | 23.16 |
| Elekta AB (EKTAY) | Sweden | $1.806B | 17.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.156B | 6.62 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.07 |
| Beta Bionics (BBNX) | United States | $0.813B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.717B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.582B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.453B | 3.64 |
| AngioDynamics (ANGO) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| RxSight (RXST) | United States | $0.374B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.371B | 9.43 |
| Spectral Diagnostics (EDTXF) | Canada | $0.305B | 0.00 |
| NeuroPace (NPCE) | United States | $0.301B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.294B | 20.26 |
| Alpha Tau Medical (DRTS) | Israel | $0.285B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.235B | 0.00 |
| Neuronetics (STIM) | United States | $0.227B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.212B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.083B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.30 |